NGR-hTNF plus chemotherapy as first-line therapy of non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Gregorc, Vanesa
Zilembo, Nicoletta
Grossi, Francesco
De Pas, Tommaso M.
Rossoni, Gilda
Pietrantonio, Filippo
Rijavec, Erika
Giovannini, Monica
Citterio, Giovanni
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[2] IRCCSS Fdn Ist Nazl Tumori, Dept Oncol, Milan, Italy
[3] Natl Canc Res Ctr, Lung Canc Unit, Genoa, Italy
[4] Ist Europeo Oncol, Unit Resp Tract & Sarcomas, Milan, Italy
[5] MolMed, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7581
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
    Fennell, D. A.
    Summers, Y.
    Cadranel, J.
    Benepal, T.
    Christoph, D. C.
    Lal, R.
    Das, M.
    Maxwell, F.
    Visseren-Grul, C.
    Ferry, D.
    [J]. CANCER TREATMENT REVIEWS, 2016, 44 : 42 - 50
  • [43] Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
    Younes, Riad Naim
    Pereira, Jost Rodrigues
    Fares, Abdo Latif
    Gross, Jefferson Luiz
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2011, 57 (06): : 686 - 691
  • [44] Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer
    Puneet Saxena
    Pawan Kumar Singh
    Prabhat Singh Malik
    Navneet Singh
    [J]. Current Treatment Options in Oncology, 2020, 21
  • [45] Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer
    Saxena, Puneet
    Singh, Pawan Kumar
    Malik, Prabhat Singh
    Singh, Navneet
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (08)
  • [46] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
  • [47] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab plus /- chemotherapy in non-small cell lung cancer (NSCLC).
    Ricciuti, Biagio
    Champagne, Christine
    Jones, Greg
    Lazarus, Tadd Scott
    Adeni, Anika E.
    Cheng, Michael L.
    Oxnard, Geoffrey R.
    Awad, Mark M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Pembrolizumab for the first-line treatment of non-small cell lung cancer
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
  • [50] Pemetrexed in first-line treatment of non-small cell lung cancer
    Esteban, Emilio
    Casillas, Marta
    Cassinello, Alejo
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (04) : 364 - 373
12345